Chapter 1. Introduction1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive SummaryChapter 4. Market Outlook4.1. Market Dynamics
4.1.1. Market Drivers
4.1.2. Market Restraints
4.1.3. Market Opportunities
4.2. Porter’s Analysis
4.3. Value Chain Analysis
Chapter 5. Surgical Suture Market, By Product Type5.1. Surgical Suture Market, by Product Type, 2018-2026
5.1.1. Absorbable Sutures
5.1.1.1. Natural Sutures
5.1.1.2. Synthetic Sutures
5.1.2. Non-Absorbable Sutures
5.1.2.1. Nylon Sutures
5.1.2.2. Polypropylene Sutures
5.1.2.3. Stainless Steel Sutures
Chapter 6. Surgical Suture Market, By Application6.1. Surgical Suture Market, by Application, 2018-2026
6.1.1. General Surgery
6.1.2. Gynecological Surgeries
6.1.3. Cardiovascular Surgeries
6.1.4. Orthopedic Surgeries
6.1.5. Other Surgeries
Chapter 7. Surgical Suture Market, By End-User7.1. Surgical Suture Market, by End-user, 2018-2026
7.2. Hospitals
7.3. Specialty Clinics
7.4. Ambulatory Surgery Centers
Chapter 8. Surgical Suture Market, By Region8.1. Surgical Suture Market, by Region, 2018-2026
8.1.1. North America
8.1.1.1. U.S
8.1.1.2. Rest of North America
8.1.2. Europe
8.1.2.1. U.K.
8.1.2.2. Germany
8.1.2.3. France
8.1.2.4. Rest of the Europe
8.1.3. Middle East & Africa (MEA)
8.1.3.1. GCC
8.1.3.2. North Africa
8.1.3.3. South Africa
8.1.3.4. Rest of MEA
8.1.4. Latin America (LATAM)
8.1.4.1. Brazil
8.1.4.2. Rest of LATAM
8.1.5. Asia Pacific (APAC)
8.1.5.1. India
8.1.5.2. China
8.1.5.3. Japan
8.1.5.4. Rest of the APAC
Chapter 9. Competitive Landscape9.1.1. Key Strategies Adopted by Players
9.1.2. Market Share/Positioning Analysis
Chapter 10. Company Profiles10.1. ConMed Corp.
10.1.1. Company Overview
10.1.2. Product Offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives
10.2. Teleflex Inc.
10.2.1. Company Overview
10.2.2. Product Offerings
10.2.3. Financial Performance
10.2.4. Recent Initiatives
10.3. Zimmer Biomet Holdings Inc.
10.3.1. Company Overview
10.3.2. Product Offerings
10.3.3. Financial Performance
10.3.4. Recent Initiatives
10.4. Integra LifeSciences Corp.
10.4.1. Company Overview
10.4.2. Product Offerings
10.4.3. Financial Performance
10.4.4. Recent Initiatives
10.5. Medtronic Plc
10.5.1. Company Overview
10.5.2. Product Offerings
10.5.3. Financial Performance
10.5.4. Recent Initiatives
10.6. B. Braun Melsungen AG
10.6.1. Company Overview
10.6.2. Product Offerings
10.6.3. Financial Performance
10.6.4. Recent Initiatives
10.7. Johnson & Johnson
10.7.1. Company Overview
10.7.2. Product Offerings
10.7.3. Financial Performance
10.7.4. Recent Initiatives
10.8. Smith & Nephew Plc
10.8.1. Company Overview
10.8.2. Product Offerings
10.8.3. Financial Performance
10.8.4. Recent Initiatives
10.9. Boston Scientific Corp.
10.9.1. Company Overview
10.9.2. Product Offerings
10.9.3. Financial Performance
10.9.4. Recent Initiatives
10.10. Acelity L.P. Inc.
10.10.1. Company Overview
10.10.2. Product Offerings
10.10.3. Financial Performance
10.10.4. Recent Initiatives
Chapter 11. Appendix11.1. About Us
11.2. Glossary of Terms